Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA027657 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA027657, RRID:AB_10611527
- Product name
- Anti-CGN
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human CGN, Gene description: cingulin, Alternative Gene Names: KIAA1319, Validated applications: WB, IHC, Uniprot ID: Q9P2M7, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Dual role of CASP8AP2/FLASH in regulating epithelial-to-mesenchymal transition plasticity (EMP)
Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer’s disease
Phosphorylated cingulin localises GEF-H1 at tight junctions to protect vascular barriers in blood endothelial cells
4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
Catalanotto M, Vaz J, Abshire C, Youngblood R, Chu M, Levine H, Jolly M, Dragoi A
Translational Oncology 2024;39
Translational Oncology 2024;39
Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer’s disease
Zhang M, Zhang Z, Li H, Xia Y, Xing M, Xiao C, Cai W, Bu L, Li Y, Park T, Tang Y, Ye X, Lin W
Translational Neurodegeneration 2024;13(1)
Translational Neurodegeneration 2024;13(1)
Phosphorylated cingulin localises GEF-H1 at tight junctions to protect vascular barriers in blood endothelial cells
Holzner S, Bromberger S, Wenzina J, Neumüller K, Holper T, Petzelbauer P, Bauer W, Weber B, Schossleitner K
Journal of Cell Science 2021;134(17)
Journal of Cell Science 2021;134(17)
4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
De Marchi T, Liu N, Stingl C, Timmermans M, Smid M, Look M, Tjoa M, Braakman R, Opdam M, Linn S, Sweep F, Span P, Kliffen M, Luider T, Foekens J, Martens J, Umar A
Molecular Oncology 2015;10(1):24-39
Molecular Oncology 2015;10(1):24-39
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human small intestine and lymph node tissues using Anti-CGN antibody. Corresponding CGN RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol